2004
DOI: 10.1016/j.ejphar.2004.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
53
1

Year Published

2005
2005
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 95 publications
(62 citation statements)
references
References 38 publications
8
53
1
Order By: Relevance
“…By 3 months of age, FSL and FRL rats spend the same amount of time in the open areas of these behavioral tests. But in other behavioral studies, such as the social interaction and active avoidance tasks, 3-month-old FSL rats exhibit increased anxiogenic behavior compared with age-matched FRL rats (Overstreet et al, 2004;Overstreet et al, 1990). These studies raise the possibility of more drastic changes in the anxiety/depression profile of FSL rats as they continue to age (Braw et al, 2006); which may explain the why only 12-to 15-month-old FSL rats showed differences in resting and rapid glutamate transients.…”
Section: Discussionmentioning
confidence: 88%
“…By 3 months of age, FSL and FRL rats spend the same amount of time in the open areas of these behavioral tests. But in other behavioral studies, such as the social interaction and active avoidance tasks, 3-month-old FSL rats exhibit increased anxiogenic behavior compared with age-matched FRL rats (Overstreet et al, 2004;Overstreet et al, 1990). These studies raise the possibility of more drastic changes in the anxiety/depression profile of FSL rats as they continue to age (Braw et al, 2006); which may explain the why only 12-to 15-month-old FSL rats showed differences in resting and rapid glutamate transients.…”
Section: Discussionmentioning
confidence: 88%
“…Several drugs have produced an AD-like effect after just 5 days of treatment. These include desipramine, a tricyclic antidepressant; nemifitide, an analog of melanocyte inhibitory factor; and a corticotropinreleasing factor 1 receptor antagonist (Overstreet and Griebel, 2004;Overstreet et al, 2004aOverstreet et al, ,b, 2008. 3.…”
Section: Antidepressant-like Effectsmentioning
confidence: 99%
“…Thus, for the functional validation of some transcripts identified as possible drug targets, further studies will be necessary to assess the effect of transcriptional regulation in one or more rodent models of depression. [38][39][40][41][42][43] Another apparent limitation is that transcriptional profiles for the different treatments were compared only at the time points corresponding to clinical efficacy, which differed for each treatment being 2 days for ECT, 1 day for SD and 14 days for FLX. Thus, a comparative analysis of transcriptional changes induced at the same time points for all treatments is missing.…”
Section: Number Of Transcripts Affected By Single and Multiple Treatmmentioning
confidence: 99%